Privia Health Group Inc PRVA

$20.30 +0.27 (1.35%)

Valuation

Market cap
2,558,512,000
Revenue TTM
$2,122,840,000
Net income TTM
$22,920,000
PE ratio
93.76
Forward PE
74.30
Profit margin
1.08%
Debt to equity
0.00

Trading

Volume
1,284,100
Avg volume
1,225,106
Day's range
$19.96 – $20.33
Shares out
127,734,000
Stochastic %K
95%
Beta
0.80
Analysts
Strong Sell
Price target
$31.67

Price

Company profile

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that...

Show more

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Industry
Health Information Services
Sector
Healthcare
Phone
571 366 8850
Website
https://www.priviahealth.com
Address
950 North Glebe Road, Suite 700, Arlington, United States

Latest news

No headlines yet.